Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia

Alessandra Carobbio, Guido Finazzi, Juergen Thiele, Hans Michael Kvasnicka, Francesco Passamonti, Elisa Rumi, Marco Ruggeri, Francesco Rodeghiero, Maria Luigia Randi, Irene Bertozzi, Alessandro M. Vannucchi, Elisabetta Antonioli, Heinz Gisslinger, Veronika Buxhofer-Ausch, Naseema Gangat, Alessandro Rambaldi, Ayalew Tefferi, Tiziano Barbui

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

According to World Health Organization (WHO)-defined criteria, patients presenting clinically as essential thrombocythemia (ET) may show early primary myelofibrosis (PMF) with accompanying thrombocythemia. Previous clinicopathological studies revealed that laboratory parameters like gender-matched hemoglobin (Hb), white blood cell (WBC) count, and particularly lactate dehydrogenase (LDH) values are significantly different in PMF. By strictly applying the WHO criteria, our investigation was aimed to study sensitivity and specificity of these features in an exploratory cohort of 536 patients and to validate the results on an independently recruited series of 321 strictly corresponding patients. The discriminatory power of these parameters (Hb, WBC, and LDH) was tested by plotting their receiver operating characteristic curves. The best performance was found for LDH (areas under the curve, AUC = 0.7059). WBC and Hb had superimposable curves, with AUC of 0.6279 and 0.6257, respectively. A diagnostic algorithm was generated by applying these parameters in a stepwise fashion. Nearly half of the patients could be correctly allocated to WHO-defined ET or early PMF in both cohorts investigated. It is important to note that this result does not substitute bone marrow morphology with hematological parameters, however, in clinical practice may alert physicians to get more suspicious of early PMF in a patient presumably presenting with ET.

Original languageEnglish
Pages (from-to)203-204
Number of pages2
JournalAmerican Journal of Hematology
Volume87
Issue number2
DOIs
Publication statusPublished - Feb 2012

Fingerprint

Essential Thrombocythemia
Primary Myelofibrosis
Hematologic Tests
L-Lactate Dehydrogenase
Area Under Curve
Hemoglobins
Leukocytes
Thrombocytosis
Leukocyte Count
ROC Curve
Bone Marrow
Physicians
Sensitivity and Specificity

ASJC Scopus subject areas

  • Hematology

Cite this

Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia. / Carobbio, Alessandra; Finazzi, Guido; Thiele, Juergen; Kvasnicka, Hans Michael; Passamonti, Francesco; Rumi, Elisa; Ruggeri, Marco; Rodeghiero, Francesco; Luigia Randi, Maria; Bertozzi, Irene; Vannucchi, Alessandro M.; Antonioli, Elisabetta; Gisslinger, Heinz; Buxhofer-Ausch, Veronika; Gangat, Naseema; Rambaldi, Alessandro; Tefferi, Ayalew; Barbui, Tiziano.

In: American Journal of Hematology, Vol. 87, No. 2, 02.2012, p. 203-204.

Research output: Contribution to journalArticle

Carobbio, A, Finazzi, G, Thiele, J, Kvasnicka, HM, Passamonti, F, Rumi, E, Ruggeri, M, Rodeghiero, F, Luigia Randi, M, Bertozzi, I, Vannucchi, AM, Antonioli, E, Gisslinger, H, Buxhofer-Ausch, V, Gangat, N, Rambaldi, A, Tefferi, A & Barbui, T 2012, 'Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia', American Journal of Hematology, vol. 87, no. 2, pp. 203-204. https://doi.org/10.1002/ajh.22241
Carobbio, Alessandra ; Finazzi, Guido ; Thiele, Juergen ; Kvasnicka, Hans Michael ; Passamonti, Francesco ; Rumi, Elisa ; Ruggeri, Marco ; Rodeghiero, Francesco ; Luigia Randi, Maria ; Bertozzi, Irene ; Vannucchi, Alessandro M. ; Antonioli, Elisabetta ; Gisslinger, Heinz ; Buxhofer-Ausch, Veronika ; Gangat, Naseema ; Rambaldi, Alessandro ; Tefferi, Ayalew ; Barbui, Tiziano. / Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia. In: American Journal of Hematology. 2012 ; Vol. 87, No. 2. pp. 203-204.
@article{50367adca79a4ab78aa696360784594e,
title = "Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia",
abstract = "According to World Health Organization (WHO)-defined criteria, patients presenting clinically as essential thrombocythemia (ET) may show early primary myelofibrosis (PMF) with accompanying thrombocythemia. Previous clinicopathological studies revealed that laboratory parameters like gender-matched hemoglobin (Hb), white blood cell (WBC) count, and particularly lactate dehydrogenase (LDH) values are significantly different in PMF. By strictly applying the WHO criteria, our investigation was aimed to study sensitivity and specificity of these features in an exploratory cohort of 536 patients and to validate the results on an independently recruited series of 321 strictly corresponding patients. The discriminatory power of these parameters (Hb, WBC, and LDH) was tested by plotting their receiver operating characteristic curves. The best performance was found for LDH (areas under the curve, AUC = 0.7059). WBC and Hb had superimposable curves, with AUC of 0.6279 and 0.6257, respectively. A diagnostic algorithm was generated by applying these parameters in a stepwise fashion. Nearly half of the patients could be correctly allocated to WHO-defined ET or early PMF in both cohorts investigated. It is important to note that this result does not substitute bone marrow morphology with hematological parameters, however, in clinical practice may alert physicians to get more suspicious of early PMF in a patient presumably presenting with ET.",
author = "Alessandra Carobbio and Guido Finazzi and Juergen Thiele and Kvasnicka, {Hans Michael} and Francesco Passamonti and Elisa Rumi and Marco Ruggeri and Francesco Rodeghiero and {Luigia Randi}, Maria and Irene Bertozzi and Vannucchi, {Alessandro M.} and Elisabetta Antonioli and Heinz Gisslinger and Veronika Buxhofer-Ausch and Naseema Gangat and Alessandro Rambaldi and Ayalew Tefferi and Tiziano Barbui",
year = "2012",
month = "2",
doi = "10.1002/ajh.22241",
language = "English",
volume = "87",
pages = "203--204",
journal = "American Journal of Hematology",
issn = "0361-8609",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - Blood tests may predict early primary myelofibrosis in patients presenting with essential thrombocythemia

AU - Carobbio, Alessandra

AU - Finazzi, Guido

AU - Thiele, Juergen

AU - Kvasnicka, Hans Michael

AU - Passamonti, Francesco

AU - Rumi, Elisa

AU - Ruggeri, Marco

AU - Rodeghiero, Francesco

AU - Luigia Randi, Maria

AU - Bertozzi, Irene

AU - Vannucchi, Alessandro M.

AU - Antonioli, Elisabetta

AU - Gisslinger, Heinz

AU - Buxhofer-Ausch, Veronika

AU - Gangat, Naseema

AU - Rambaldi, Alessandro

AU - Tefferi, Ayalew

AU - Barbui, Tiziano

PY - 2012/2

Y1 - 2012/2

N2 - According to World Health Organization (WHO)-defined criteria, patients presenting clinically as essential thrombocythemia (ET) may show early primary myelofibrosis (PMF) with accompanying thrombocythemia. Previous clinicopathological studies revealed that laboratory parameters like gender-matched hemoglobin (Hb), white blood cell (WBC) count, and particularly lactate dehydrogenase (LDH) values are significantly different in PMF. By strictly applying the WHO criteria, our investigation was aimed to study sensitivity and specificity of these features in an exploratory cohort of 536 patients and to validate the results on an independently recruited series of 321 strictly corresponding patients. The discriminatory power of these parameters (Hb, WBC, and LDH) was tested by plotting their receiver operating characteristic curves. The best performance was found for LDH (areas under the curve, AUC = 0.7059). WBC and Hb had superimposable curves, with AUC of 0.6279 and 0.6257, respectively. A diagnostic algorithm was generated by applying these parameters in a stepwise fashion. Nearly half of the patients could be correctly allocated to WHO-defined ET or early PMF in both cohorts investigated. It is important to note that this result does not substitute bone marrow morphology with hematological parameters, however, in clinical practice may alert physicians to get more suspicious of early PMF in a patient presumably presenting with ET.

AB - According to World Health Organization (WHO)-defined criteria, patients presenting clinically as essential thrombocythemia (ET) may show early primary myelofibrosis (PMF) with accompanying thrombocythemia. Previous clinicopathological studies revealed that laboratory parameters like gender-matched hemoglobin (Hb), white blood cell (WBC) count, and particularly lactate dehydrogenase (LDH) values are significantly different in PMF. By strictly applying the WHO criteria, our investigation was aimed to study sensitivity and specificity of these features in an exploratory cohort of 536 patients and to validate the results on an independently recruited series of 321 strictly corresponding patients. The discriminatory power of these parameters (Hb, WBC, and LDH) was tested by plotting their receiver operating characteristic curves. The best performance was found for LDH (areas under the curve, AUC = 0.7059). WBC and Hb had superimposable curves, with AUC of 0.6279 and 0.6257, respectively. A diagnostic algorithm was generated by applying these parameters in a stepwise fashion. Nearly half of the patients could be correctly allocated to WHO-defined ET or early PMF in both cohorts investigated. It is important to note that this result does not substitute bone marrow morphology with hematological parameters, however, in clinical practice may alert physicians to get more suspicious of early PMF in a patient presumably presenting with ET.

UR - http://www.scopus.com/inward/record.url?scp=84855932927&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855932927&partnerID=8YFLogxK

U2 - 10.1002/ajh.22241

DO - 10.1002/ajh.22241

M3 - Article

C2 - 22237692

AN - SCOPUS:84855932927

VL - 87

SP - 203

EP - 204

JO - American Journal of Hematology

JF - American Journal of Hematology

SN - 0361-8609

IS - 2

ER -